Comparative study between the effect of Single Anastomosis Gastric Bypass versus Roux-en-Y gastric Bypass in morbidly obese patient as regard remission of type-2 DM

Abstract

ccumulating evidence obviously supports the superiority of weight loss surgery over non-surgical treatments for management of morbidly obese patients in terms of outcomes as sustained weight loss, improved quality of life and prevention, reduction, or resolution of co-morbidities (e.g., Type 2 Diabetes Mellitus, dyslipidemia), as well as reduced overall mortality. Over 12 months we compared Single anastomosis Gastric bypass to laparoscopic Roux-en-Y gastric bypass (RY-GBP) as a bariatric surgery for morbidly obese patients with T2BM. The Roux-en-Y operation is more potent as regard remission of T2DM than MGB/OAGB. We compare both of them as regard remission of DM in patients with BMI 30-40 with referral to DIAREM SCORING SYSTEM. Conclusion: 1. No statistical difference between both groups as regard remission of DM however numerically it is obvious that Roux-en-Y is more potent metabolic surgery in order to be statistically significant the study needs to be repeated over larger sample size. 2. The main determinant noticed during the study influencing remission is the duration of DM and preoperative C-peptide level-in addition to HBA1C level.